Chemours Reports Shareholder Vote Results
Ticker: CC · Form: 8-K · Filed: May 23, 2024 · CIK: 1627223
| Field | Detail |
|---|---|
| Company | Chemours Co (CC) |
| Form Type | 8-K |
| Filed Date | May 23, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting, auditor-ratification
Related Tickers: CC
TL;DR
Chemours shareholders voted on directors and auditors; results are in.
AI Summary
On May 21, 2024, The Chemours Company filed an 8-K to report on matters submitted to a vote of its security holders. The filing details the outcomes of a shareholder meeting, including the election of directors and the ratification of PricewaterhouseCoopers LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2024.
Why It Matters
This filing provides transparency on key corporate governance decisions made by Chemours' shareholders, including the composition of its board and the oversight of its financial auditing.
Risk Assessment
Risk Level: low — This is a routine corporate filing detailing shareholder votes and has no immediate financial implications.
Key Players & Entities
- The Chemours Company (company) — Registrant
- PricewaterhouseCoopers LLP (company) — Independent registered public accounting firm
- May 21, 2024 (date) — Date of earliest event reported
- December 31, 2024 (date) — Fiscal year end for auditor ratification
FAQ
What was the primary purpose of this 8-K filing?
The primary purpose was to report on matters submitted to a vote of The Chemours Company's security holders, specifically detailing the outcomes of a shareholder meeting.
When was the earliest event reported in this filing?
The earliest event reported was on May 21, 2024.
Who was ratified as Chemours' independent registered public accounting firm?
PricewaterhouseCoopers LLP was ratified as Chemours' independent registered public accounting firm for the fiscal year ending December 31, 2024.
What is Chemours' state of incorporation?
The Chemours Company is incorporated in Delaware.
What is the principal executive office address for Chemours?
The principal executive offices are located at 1007 Market Street, Wilmington, Delaware 19801.
Filing Stats: 538 words · 2 min read · ~2 pages · Grade level 9.8 · Accepted 2024-05-23 16:20:14
Key Financial Figures
- $0.01 — nge on Which Registered Common Stock ($0.01 par value) CC New York Stock Exchan
Filing Documents
- cc-20240521.htm (8-K) — 71KB
- img172685009_0.jpg (GRAPHIC) — 35KB
- 0000950170-24-063967.txt ( ) — 274KB
- cc-20240521.xsd (EX-101.SCH) — 29KB
- cc-20240521_htm.xml (XML) — 4KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. The Chemours Company (the "Company") held its annual meeting of shareholders on May 21, 2024 (the "Annual Meeting"). At the Annual Meeting, shareholders: elected all nine director nominees to serve a one-year term; approved the Company's annual "say-on-pay" vote on an advisory basis; and ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm. The final voting results for each proposal were as follows: Proposal 1 – Election of Directors to Serve One-Year Term Nominee For Against Abstain Broker Non-Votes Curtis V. Anastasio 107,037,011 (93.8%) 7,108,377 230,686 16,051,105 Alister Cowan 110,687,093 (97.0%) 3,380,796 308,190 16,051,100 Mary B. Cranston 104,603,238 (91.6%) 9,551,712 221,133 16,051,096 Denise Dignam 110,820,826 (97.0%) 3,379,513 175,743 16,051,097 Dawn L. Farrell 109,748,954 (96.1%) 4,443,895 183,226 16,051,104 Pamela F. Fletcher 110,604,858 (97.0%) 3,459,155 312,065 16,051,101 Erin N. Kane 110,423,007 (96.7%) 3,730,068 223,002 16,051,102 Sean D. Keohane 108,173,264 (94.8%) 5,971,150 231,664 16,051,101 Guillaume Pepy 109,832,724 (96.2%) 4,311,317 232,036 16,051,102 Proposal 2 – Advisory Vote to Approve Named Executive Officer Compensation For Against Abstain Broker Non-Votes 108,041,241 (94.5%) 5,954,933 379,891 16,051,114 Proposal 3 – Ratification of Selection of Independent Registered Public Accounting Firm For Against Abstain Broker Non-Votes 127,719,648 (97.9%) 2,491,323 216,208 n/a
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE CHEMOURS COMPANY By: /s/ Matthew S. Abbott Matthew S. Abbott Interim Chief Financial Officer Date: May 23, 2024